OGT Launches NGS Panel to Detect Residual Disease in Acute Myeloid Leukemia
The RNA-based panel detects leukemia-associated gene fusions at levels as low as 1% tumor cells, offering another approach to monitoring residual disease.
Category: Leukemia
Leukemia
Latest
Leukemia
Latest
Investigational AI Tool Cuts Acute Leukemia Diagnosis Time to Two Hours
MARLIN uses DNA methylation patterns and machine learning to classify leukemia subtypes, potentially accelerating treatment decisions.
Leukemia
Latest
RNA Sequencing Analysis May Offer More Accurate Diagnosis for Common Pediatric Cancer
A pilot study proposes a promising clinically applicable genomic assay for the diagnosis of a heterogeneous pediatric leukemia.
QIAGEN and Servier Will Develop CDx for Acute Myeloid Leukemia Therapy Drug
QIAGEN and Servier are partnering to develop a CDx test for TIBSOVO, an isocitrate dehydrogenase-1 inhibitor indicated for AML treatment.
Read More
Blood Test Identifies Acute Myeloid Leukemia Patients at Risk for Relapse
Research shows benefits of screening patients in remission from acute myeloid leukemia for residual disease prior to a bone marrow transplant.
Read More
Faster Genomics-Based Diagnosis May Accelerate Treatment of Myeloid Neoplasms Patients
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read More
Alercell Launches Website Dedicated to New Cancer Detection Tests
Alercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Read More
Alercell Launching Leukemia Diagnostic Test
Alercell is launching a leukemia diagnostic test based on sequencing DNA that will detect up to 51 Genes mutations in Leukemia patients.
Read More
Powerful New Tools to Diagnosis Blood Cancers in Development
Scientists are using new technology to improve the diagnosis and treatment of blood cancers, which affect 1.24 million people globally.
Read More
Simple Blood Test Predicts Neurotoxic Complications of CAR-T Cell Therapy
CAR-T cell therapy has revolutionized the treatment of several cancers, using modified T cells to target types of leukemia & lymphoma.
Read More
Researchers Discover Cells That Can Transform into Leukemia
Everyone has a small number of an unusual thymocyte cell, which can become a form of leukemia called T-cell acute lymphoblastic leukemia.
Read More
NIH Awards Grant for Autofluorescence-Free Cytometry Development
Kinetic River has been awarded a Phase II SBIR grant for the development of an autofluorescence-free flow cytometry platform.
Read More
Acute Myeloid Leukemia Subtypes Help Treatment
To better treat patients with acute myeloid leukemia, researchers discovered a novel subtype of the cancer via proteome and genetic analysis.
Read More
Improved Monitor of Cancer Recurrence in Leukemia Patients Through New Protocol
Researchers have developed a new protocol for monitoring acute lymphoblastic leukemia to inform more effective treatment strategies.
Read More
BioFluidica to Commericalize LiquidScan Biopsy System
BioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.Â
Read More
Qlucore Awarded Grant to Aid Clinical Diagnostics of Cancer
The grant will allow Qlucore to expand Qlucore Diagnostics software with a focus on RNA-profiling of glioma and acute leukemia.
Read More
Study Demonstrates New Tool for Rapid Evaluation of Acute Leukemia Patients
PixCell’s HemoScreen may be used to monitor pathological blood samples, improving treatment process for hematological patients.
Read More
Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Read More